Commonly used mouse strains have distinct vascular properties.
Mouse model
Strains
Vasculature
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
24
12
2019
accepted:
20
04
2020
revised:
07
04
2020
pubmed:
16
5
2020
medline:
12
10
2021
entrez:
16
5
2020
Statut:
ppublish
Résumé
Mice are the most common animal model to investigate human disease and explore physiology. Mice are practical, cost efficient, and easily used for genetic manipulations. Although variability in cardiac structure and function among mouse strains is well noted, the effect of mouse strain on vascular stiffness indices is not known. Here, we compared mouse strain-dependent differences in key vascular stiffness indices among frequently used inbred mouse strains-C57Bl/6J, 129S, and Bl6/129S. In young healthy animals, baseline blood pressure and heart rate were identical in all strains, and independent of gender. However, both active in vivo and passive ex vivo vascular stiffness indices exhibited distinct differences. Specifically, both male and female 129S animals demonstrated the highest tensile stiffness, were least responsive to acetylcholine-induced vasorelaxation, and showed the lowest pulse wave velocity (PWV), an index of in vivo stiffness. C57Bl/6J mice demonstrated the highest PWV, lowest tensile stiffness, and the highest response to acetylcholine-induced vasorelaxation. Interestingly, within each strain, female mice had more compliant aortas. C57Bl/6J mice had thinner vessel walls with fewer layers, whereas 129S mice had the thickest walls with the most layers. Values in the Bl6/129S mixed background mice fell between C57Bl/6J and 129S mice. In conclusion, we show that underlying vascular properties of different inbred wild-type mouse strains are distinct, despite superficial similarities in blood pressure. For each genetic modification, care should be taken to identify proper controls, and conclusions might need to be verified in more than one strain to minimize the risk of false positive studies.
Identifiants
pubmed: 32409775
doi: 10.1038/s41440-020-0467-4
pii: 10.1038/s41440-020-0467-4
pmc: PMC7926191
mid: NIHMS1672961
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1175-1181Subventions
Organisme : NHLBI NIH HHS
ID : K08 HL145132
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148112
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Doevendans PA, Daemen MJ, de Muinck ED, Smits JF. Cardiovascular phenotyping in mice. Cardiovasc Res. 1998;39:34–49.
doi: 10.1016/S0008-6363(98)00073-X
Schlager G, Weibust RS. Genetic control of blood pressure in mice. Genetics. 1967;55:497–506.
pubmed: 6038422
pmcid: 1211405
Barnabei MS, Palpant NJ, Metzger JM. Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strains. Physiol Genom. 2010;42A:103–13.
doi: 10.1152/physiolgenomics.00071.2010
Hoit BD, Kiatchoosakun S, Restivo J, Kirkpatrick D, Olszens K, Shao H, et al. Naturally occurring variation in cardiovascular traits among inbred mouse strains. Genomics. 2002;79:679–85.
doi: 10.1006/geno.2002.6754
Ryan MJ, Didion SP, Davis DR, Faraci FM, Sigmund CD. Endothelial dysfunction and blood pressure variability in selected inbred mouse strains. Arterioscler Thromb Vasc Biol. 2002;22:42–8.
doi: 10.1161/hq0102.101098
Fujii M, Hara H, Meng W, Vonsattel JP, Huang Z, Moskowitz MA. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke. 1997;28:1805–10.
doi: 10.1161/01.STR.28.9.1805
Di Lazzaro V, Pilato F, Dileone M, Tonali PA, Ziemann U. Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition. J Physiol. 2005;569:315–23.
doi: 10.1113/jphysiol.2005.092155
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–27.
doi: 10.1016/j.jacc.2009.10.061
Steppan J, Barodka V, Berkowitz DE, Nyhan D. Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol Res Pract. 2011;2011:263585.
doi: 10.4061/2011/263585
Oh YJ, Pau VC, Steppan J, Sikka G, Bead VR, Nyhan D, et al. Role of tissue transglutaminase in age-associated ventricular stiffness. Amino Acids. 2017;49:695–704.
doi: 10.1007/s00726-016-2295-z
Steppan J, Wang H, Bergman Y, Rauer MJ, Tan S, Jandu S, et al. Lysyl oxidase-like 2 depletion is protective in age-associated vascular stiffening. Am J Physiol Heart Circ Physiol. 2019;317:H49–59.
doi: 10.1152/ajpheart.00670.2018
Steppan J, Sikka G, Jandu S, Barodka V, Halushka MK, Flavahan NA, et al. Exercise, vascular stiffness, and tissue transglutaminase. J Am Heart Assoc. 2014;3:e000599.
doi: 10.1161/JAHA.113.000599
Jung SM, Jandu S, Steppan J, Belkin A, An SS, Pak A, et al. Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. Am J Physiol Heart Circ Physiol. 2013;305:H803–10.
doi: 10.1152/ajpheart.00103.2013
Steppan J, Bergman Y, Viegas K, Armstrong D, Tan S, Wang H, et al. Tissue transglutaminase modulates vascular stiffness and function through crosslinking-dependent and crosslinking-independent functions. J Am Heart Assoc. 2017;6:2.
doi: 10.1161/JAHA.116.004161
Barreto Ortiz S, Hori D, Nomura Y, Yun X, Jiang H, Yong H, et al. Opsin 3 and 4 mediate light-induced pulmonary vasorelaxation that is potentiated by G protein-coupled receptor kinase 2 inhibition. Am J Physiol Lung Cell Mol Physiol. 2018;314:L93–106.
doi: 10.1152/ajplung.00091.2017
Hori D, Dunkerly-Eyring B, Nomura Y, Biswas D, Steppan J, Henao-Mejia J, et al. miR-181b regulates vascular stiffness age dependently in part by regulating TGF-beta signaling. PLoS ONE. 2017;12:e0174108.
doi: 10.1371/journal.pone.0174108
Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genom. 2016;48:826–34.
doi: 10.1152/physiolgenomics.00089.2016
Steppan J, Tran HT, Bead VR, Oh YJ, Sikka G, Bivalacqua TJ, et al. Arginase inhibition reverses endothelial dysfunction, pulmonary hypertension, and vascular stiffness in transgenic sickle cell mice. Anesth Analg. 2016;123:652–8.
doi: 10.1213/ANE.0000000000001378
Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89:957–89.
doi: 10.1152/physrev.00041.2008
Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932–43.
doi: 10.1161/01.ATV.0000160548.78317.29
Steppan J, Tran H, Benjo AM, Pellakuru L, Barodka V, Ryoo S, et al. Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness. Exp Gerontol. 2012;47:565–72.
doi: 10.1016/j.exger.2012.04.006